| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | CLP 2.77T | CLP 2.90T | CLP 2.57T | CLP 2.71T | CLP 2.48T |
| Gross Profit | CLP 1.23T | CLP 1.31T | CLP 1.19T | CLP 1.20T | CLP 1.19T |
| Operating Income | CLP 203.12B | CLP 262.61B | CLP 239.97B | CLP 218.76B | CLP 330.47B |
| EBITDA | CLP 350.84B | CLP 262.70B | CLP 344.05B | CLP 211.68B | CLP 454.00B |
| Net Income | CLP 111.40B | CLP 160.94B | CLP 105.65B | CLP 118.17B | CLP 199.16B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | CLP 530.62B | CLP 707.95B | CLP 621.47B | CLP 609.04B | CLP 279.58B |
| Total Assets | CLP 3.76T | CLP 3.99T | CLP 3.42T | CLP 3.60T | CLP 2.85T |
| Total Debt | CLP 1.33T | CLP 1.41T | CLP 1.33T | CLP 1.37T | CLP 573.65B |
| Net Debt | CLP 806.90B | CLP 707.45B | CLP 711.11B | CLP 775.48B | CLP 308.08B |
| Total Liabilities | CLP 2.14T | CLP 2.32T | CLP 2.09T | CLP 2.16T | CLP 1.42T |
| Stockholders' Equity | CLP 1.48T | CLP 1.53T | CLP 1.22T | CLP 1.32T | CLP 1.31T |
| Cash Flow | |||||
| Free Cash Flow | CLP 91.92B | CLP 127.43B | CLP 164.65B | CLP -157.67B | CLP 121.50B |
| Operating Cash Flow | CLP 227.31B | CLP 287.52B | CLP 294.10B | CLP 45.94B | CLP 293.36B |
| Investing Cash Flow | CLP -156.23B | CLP -118.29B | CLP -137.23B | CLP -236.46B | CLP -178.99B |
| Financing Cash Flow | CLP -196.43B | CLP -125.04B | CLP -118.04B | CLP 537.10B | CLP -233.64B |